SanovaWorks

Join Dr. Pearl Grimes for her Inaugural Pigmentary Disorders Exchange Symposium May 5th and 6th in Chicago at the JW Marriott

Join Dr. Desai for A Targeted Approach to the Treatment of Nonsegmental Vitiligo on 12/1.

Be sure to save your spot, register today: https://event.on24.com/wcc/r/3987044/1FF41E8C087ECD55FDC1ED397187A0EF?partnerref=FB

Repost from

November 7th is National Retinol Day. Often referred to as the “gold standard” of therapy, the benefits of are well documented in short term studies. But few studies have looked at the efficacy and safety of continued use over a long period of time. So, for this Skincare Monday, we’re highlighting results of a 52-week study that shows the benefits of a stabilized treatment do not plateau over time.

Follow this link or the link in our bio to read the full article and download our infographic on today’s topic: https://nextstepsinderm.com/derm-topics/skincare-mondays-1-year-study-shows-retinol-benefits-do-not-plateau/

Follow this link or the link in our bio to view the recent JDD supplement: RETINOL: AN INGREDIENT WITH OVER 25 YEARS OF RESEARCH AND INNOVATION FOR COSMETIC SKIN SOLUTIONS: https://jddonline.com/articles/full-supplement-retinol-an-ingredient-with-over-25-years-of-research-and-innovation-for-cosmetic-skin-solutions-S1545961622S00s1X/

The JDD November Issue is Live! The special focus this month is Lasers, Lights Sources, and Devices.

Explore various evidence-based educational resources discussing the role of colloidal oatmeal in the management of cutaneous conditions. Visit our Oats in Skincare Resource Center today: https://jddonline.com/oats-in-skincare/

The burden of in patients with skin of color is significant, with reduced quality of life and often delayed diagnosis compared to patients with white skin. Andrew Alexis, MD, MPH, shares expert insights on how he thinks learners will benefit from participating in an enduring educational activity presented by at the 2022 annual meeting in New York. Follow the link in our bio for the full video, access to the enduring educational activity, and further reading on managing psoriasis. Repost from .

The JDD is proud to announce the launch of its newest educational resource; and partner site to The Full Spectrum of Dermatology: A Diverse and Inclusive Atlas print and e-book.

A special THANK YOU to and for their exclusive sponsorship of the online image gallery! Within the site you will find high-quality images that you will be able to use, free of charge, for non-commercial educational purposes.

As with the Atlas, this online image gallery displays side-by-side images of the most commonly seen dermatology conditions in an array of skin tones and features:
• REAL patients – REAL skin. NO computer-generated images
• 800+ full spectrum, side-by-side images
• Over 110 dermatologic conditions
• Over 100 pieces of commentary discussing the distinct features of certain conditions, clues to point the user to the correct diagnosis, and differences seen based on certain skin tones

Available now on JDDOnline.com - Featuring guest speaker Neal Bhatia, MD. Hosted by Dr. Adam Friedman. Watch here: https://jddonline.com/translational_video/jak-inhibitors-vs-biologics-in-the-atopic-wars/

During the recent DERM2O22 NP/PA CME conference held July 28-31, 2022, Drs. David Cohen, Brad Glick, and Adam Friedman led a case-based panel discussion on atopic dermatitis (AD) treatment initiation and monitoring. Onsite correspondent for the conference, Dr. Mojgan Hosseinipour, shares a summary of their discussion and recommendations. Repost from

Follow this link or the link in our bio to read the full article: https://nextstepsinderm.com/derm-topics/atopic-dermatitis-ad-treatment-initiation-and-monitoring/

"It's about saying right here, right now, we have to purposefully make a decision to be inclusive, to be welcoming to all so that we can practice at the highest level of our calling to treat everyone effectively and equitably." - Dr. Adam Friedman

The prevalence of photodamaged skin as well as the development of actinic keratoses and non-melanoma skin cancer is staggering and continues to be a major disease burden on our health care system. About 38% of Caucasians over the age of 50 have at least one in the United States. The high burden of disease costs about 920 million dollars per year and likely this number does not factor in every aspect of the evaluation, treatment, and potential complication of the disease.

During the 2022 conference, Dr. C. William Hanke led a detailed workshop where he provided clarity and therapeutic options for the treatment of in nearly every patient population. Furthermore, his talk delved in the nuances of treatment for superficial type non-melanoma skin cancers. Advisory Council Member and Onsite Correspondent for ODAC shares a detailed summary of Dr. Hanke's workshop. Repost from .

Follow this link or the link in our bio for the full article: https://nextstepsinderm.com/derm-topics/the-burden-of-long-standing-uv-radiation-exposure-treatment-options-for-aks-and-nmsc/